170 related articles for article (PubMed ID: 1635982)
1. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Rummeny EJ; Peters PE
Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV
Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
[TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Vogl TJ; Hammerstingl R; Schnell B; Eibl-Eibesfeldt B; Peqios W; Lissner J
Bildgebung; 1992 Dec; 59(4):195-9. PubMed ID: 1292771
[TBL] [Abstract][Full Text] [Related]
4. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Giovagnoni A; Paci E
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
[TBL] [Abstract][Full Text] [Related]
5. New contrast agents for imaging the liver.
Helmberger T; Semelka RC
Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):745-66, vi. PubMed ID: 11694436
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MR imaging of the pancreas.
Kettritz U; Semelka RC
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):87-100. PubMed ID: 8673719
[TBL] [Abstract][Full Text] [Related]
7. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Burke C; Alexander Grant L; Goh V; Griffin N
Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC
Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
[TBL] [Abstract][Full Text] [Related]
9. [Magnetic resonance tomography in focal diseases of the liver (review)].
Kholin AV
Vestn Rentgenol Radiol; 1990; (2):59-63. PubMed ID: 2219689
[TBL] [Abstract][Full Text] [Related]
10. [Dynamic MR tomography of intrahepatic tumors].
Hamm B; Felix R; Wolf KJ
Rofo; 1989 Apr; 150(4):434-41. PubMed ID: 2539622
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
De Gaspari A; De Cobelli F; Del Maschio A
Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
[TBL] [Abstract][Full Text] [Related]
12. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Rofsky NM; Earls JP
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
Santyr GE
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
Hamm B; Laniado M; Saini S
Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
[TBL] [Abstract][Full Text] [Related]
16. [Iron oxides as contrast agents for MRI of the liver].
Van Beers BE; Pringot J; Gallez B
J Radiol; 1995 Nov; 76(11):991-5. PubMed ID: 8594187
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Reimer P; Schneider G; Schima W
Eur Radiol; 2004 Apr; 14(4):559-78. PubMed ID: 14986050
[TBL] [Abstract][Full Text] [Related]
18. Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
Rofsky NM; Weinreb JC
Magn Reson Q; 1992 Sep; 8(3):156-68. PubMed ID: 1390058
[TBL] [Abstract][Full Text] [Related]
19. Soluble-type hepatobiliary contrast agents for MR imaging.
de Haën C; Gozzini L
J Magn Reson Imaging; 1993; 3(1):179-86. PubMed ID: 8428085
[No Abstract] [Full Text] [Related]
20. Contrast agents for MR imaging of the liver.
Balci NC; Semelka RC
Radiol Clin North Am; 2005 Sep; 43(5):887-98, viii. PubMed ID: 16098345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]